|
A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.
|
|||||||||||||||||||||||||||||||||||||||||||
|
A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.
|
|||||||||||||||||||||||||||||||||||||||||||